SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 171 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $784,000,000 | -35.6% | 50,000 | -37.5% | 0.02% | -19.0% |
| Q4 2014 | $1,217,000,000 | -6.0% | 80,000 | -33.3% | 0.02% | -4.5% |
| Q3 2014 | $1,294,000,000 | -15.3% | 120,000 | +20.0% | 0.02% | -26.7% |
| Q2 2014 | $1,527,000,000 | -63.3% | 100,000 | -56.5% | 0.03% | -62.0% |
| Q1 2014 | $4,158,000,000 | +368.2% | 230,000 | +259.6% | 0.08% | +393.8% |
| Q4 2013 | $888,000,000 | -62.3% | 63,959 | -71.6% | 0.02% | -67.3% |
| Q3 2013 | $2,358,000,000 | – | 225,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |